Germany
LinkedInMax de Rosnay is a Berlin/London-based consultant specialising in the psychedelic industry. He advises early-stage ventures on partner ecosystems, compliance frameworks, and market entry strategy. He brings 6 years of experience in the field, previously holding positions at atai Life Sciences (now atai Beckley) and MIND Foundation. He works across English, French, and German-speaking markets.
Articles by Max de Rosnay
Advanced Exploration
A Deeper Look at the U.S.’ Psychedelic Executive Order
The White House is supporting psychedelic therapies. Good news for patient access. But are safety…
